Kang Jin-Kyu, Kim Mi-Sook, Jang Won-Il, Seo Young Seok, Kim Hee Jin, Cho Chul Koo, Yoo Hyung Jun, Paik Eun Kyung, Cha Yu Jin, Song Hyun Jin
Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Radiation Medicine Policy Development Center, Korea Institute of Radiological & Medical Sciences, Seoul, Korea.
Radiat Oncol J. 2016 Jun;34(2):88-95. doi: 10.3857/roj.2016.01753. Epub 2016 Jun 30.
The purpose of this study was to estimate the clinical utilization of radiation therapy (RT) in Korea between 2009 and 2013.
We analyzed open claims data from the Health Insurance Review and Assessment Service. The subjects were patients who had diagnostic codes C00-C97 or D00-D48 according to the 10th revision of the International Classification of Diseases, with procedure codes indicating RT treatment.
The total number of patients who received RT in 2009, 2010, 2011, 2012, and 2013 were 45,571, 49,593, 54,671, 59,172, and 61,485, respectively. Among them, the total numbers of male and female patients were 20,780/24,791 in 2009, 22,711/26,882 in 2010, 24,872/29,799 in 2011, 27,101/32,071 in 2012, and 27,941/33,544 in 2013. The five cancers that were most frequently treated with RT between 2009 and 2012 were breast, lung, colorectal, liver, and uterine cervical cancers. However, the fifth most common cancer treated with RT that replaced uterine cervical cancer in 2013 was prostate cancer. The three leading types of cancer among the male patients were lung, colorectal, and liver cancers, whereas in female patients, they were breast, uterine cervical, and lung cancers. The type of cancer most commonly treated by RT was cancer of the central nervous system in patients aged 20 years or less, breast cancer in patients aged 30-50 years, and lung cancer in patients aged 60 years or more.
Data from this study provided the clinical utilization of RT in Korea between 2009 and 2013.
本研究旨在评估2009年至2013年韩国放射治疗(RT)的临床应用情况。
我们分析了健康保险审查与评估服务机构的公开理赔数据。研究对象为根据国际疾病分类第10版诊断编码为C00 - C97或D00 - D48且程序编码显示接受RT治疗的患者。
2009年、2010年、2011年、2012年和2013年接受RT治疗的患者总数分别为45,571、49,593、54,671、59,172和61,485。其中,2009年男性和女性患者总数分别为20,780/24,791,2010年为22,711/26,882,2011年为24,872/29,799,2012年为27,101/32,071,2013年为27,941/33,544。2009年至2012年接受RT治疗最频繁的五种癌症是乳腺癌、肺癌、结直肠癌、肝癌和子宫颈癌。然而,2013年取代子宫颈癌成为接受RT治疗的第五大常见癌症是前列腺癌。男性患者中三种主要癌症类型是肺癌、结直肠癌和肝癌,而女性患者中是乳腺癌、子宫颈癌和肺癌。20岁及以下患者中接受RT治疗最常见的癌症类型是中枢神经系统癌,30 - 50岁患者中是乳腺癌,60岁及以上患者中是肺癌。
本研究数据提供了2009年至2013年韩国RT的临床应用情况。